PSNL
Personalis, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$17.20
+2.20%Margins
Gross margin
12.7%
EBITDA margin
-139.5%
EBIT margin
-164.1%
Net margin
-153.8%
FCF margin
-144.9%
-45.6%
Return on equity
-34.3%
Return on assets
-41.8%
Return on invested capital
0.22x
Asset turnover
-$92.3M
Cash from operations
$1.99
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026